Biden signals interest in using NIH IP to reduce drug prices

The Biden administration has signaled that it may consider a policy change that would allow NIH to assert patent rights to reduce drug prices.

A sweeping Executive Order on promoting competition released Friday instructs the Department of Commerce to “consider not finalizing any provisions on march-in rights and product pricing” that were included in a Trump administration proposed rule on “Rights to Federally Funded Inventions and Licensing of Government Owned Inventions.”...